Pharma: How do you fail to report 80,000 adverse reactions to drugs?

[SaneVax: A recent investigation by the European Medicines Agency uncovered 80,000 adverse reactions, including 15,000 deaths, from various medications that had not been reported as required by law. Both Roche and Genentech claim this oversight was unintentional and does not affect the safety profile of any of their drugs. What is wrong with this picture?]

Pharma giant failed to report 80,000 drug files

By Andy Coghlan

Still Safe?

An investigation is under way after the discovery that 80,000 reports of patient reactions to drugs were not passed on to regulatory authorities by the Swiss-based pharmaceutical giant Roche and its US affiliate, Genentech.

The focus of the probe, by the European Medicines Agency, is to find out whether patient safety has been compromised by the unreported information, which includes 15,000 reports of patients who ultimately died of their illnesses – although there is no evidence that their deaths were a result of the drugs they took.

“We need to determine what’s going on, and have asked the companies to submit an updated corrective action plan,” said a spokeswoman for the EMA. She said that companies are legally obliged to notify regulatory authorities of any adverse drug reactions (ADRs) that come to light, but stressed that until the investigation is complete, it’s not clear how many of the 80,000 reports were of adverse reactions. “They are not necessarily ADRs,” she told New Scientist.

The cache of buried reports was discovered last month when officials from the UK Medicines and Healthcare products Regulatory Agency visited Roche’s facilities in Welwyn, UK. The EMA revealed the lapse on 21 June.

Read the entire article here.

Speak Your Mind